The Genesis Energy Ltd (ASX: GNE) share price is in focus today after the company wrapped up a NZ$300 million fully underwritten renounceable rights offer, with the shortfall bookbuild clearing at a premium and total funds raised across all offers reaching NZ$400 million.
Image source: Getty Images
What did Genesis Energy report?
- Successful completion of the NZ$300 million 1 for 7.9 renounceable rights offer
- Shortfall bookbuild cleared at NZ$2.22 per new share, NZ$0.17 above application price
- Aggregate of NZ$400 million raised, including a NZ$100 million placement
- Settlement on ASX expected 24 March 2026, NZX on 25 March 2026
- New shares to rank equally with existing Genesis Energy shares
- FY25 revenue reported at NZ$3.7 billion
What else do investors need to know?
Genesis Energy's shortfall bookbuild was well supported, delivering a premium over the general rights offer price. Eligible shareholders not taking up their full allocation, and ineligible shareholders, will receive NZ$0.17 per new share not taken up, with payment expected by 31 March 2026.
Settlement of new shares will enable trading to commence on both the NZX and the ASX. Genesis confirmed that these shares will have the same rights and status as existing ordinary shares. The company also continues as a leading NZ energy retailer with a strong mix of thermal and renewable generation assets, and a 46% stake in the Kupe Joint Venture.
What's next for Genesis Energy?
With the equity raise completed, Genesis Energy will focus on deploying these new funds to support its ongoing operational and growth initiatives. The capital injection strengthens Genesis' balance sheet and positions the business to further invest in its diverse generation portfolio.
Investors can expect updates on the company's use of proceeds and strategic roadmap, particularly around renewable energy opportunities and customer growth in New Zealand's competitive energy market.
Genesis Energy share price snapshot
Over the past 12 months, Genesis Energy shares have declined 4%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.
